Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Hayek

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Cell|October 16, 1992
Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cellsA S Plump, J D Smith, T Hayek, et al.
Journal of Lipid Research|November 5, 1997
Decreased HDL cholesterol levels but normal lipid absorption, growth, and feeding behavior in apolipoprotein A-IV knockout miceP H Weinstock, C L Bisgaier, T Hayek, et al.
The Journal of Clinical Investigation|November 1, 1992
Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particlesK Aalto-Setälä, E A Fisher, X Chen, et al.
Drugs Under Experimental and Clinical Research|September 13, 2002
Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humansM Aviram, L Dornfeld, M Kaplan, et al.
The Journal of Clinical Investigation|April 1, 1994
Overexpression of apolipoprotein CII causes hypertriglyceridemia in transgenic miceN S Shachter, T Hayek, T Leff, et al.
The Journal of Clinical Investigation|May 16, 1998
The full induction of human apoprotein A-I gene expression by the experimental nephrotic syndrome in transgenic mice depends on cis-acting elements in the proximal 256 base-pair promoter region and the trans-acting factor early growth response factor 1M Zaiou, N Azrolan, T Hayek, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Cell|October 16, 1992
Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cellsA S Plump, J D Smith, T Hayek, et al.
Journal of Lipid Research|November 5, 1997
Decreased HDL cholesterol levels but normal lipid absorption, growth, and feeding behavior in apolipoprotein A-IV knockout miceP H Weinstock, C L Bisgaier, T Hayek, et al.
The Journal of Clinical Investigation|November 1, 1992
Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particlesK Aalto-Setälä, E A Fisher, X Chen, et al.
Drugs Under Experimental and Clinical Research|September 13, 2002
Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humansM Aviram, L Dornfeld, M Kaplan, et al.
The Journal of Clinical Investigation|April 1, 1994
Overexpression of apolipoprotein CII causes hypertriglyceridemia in transgenic miceN S Shachter, T Hayek, T Leff, et al.
The Journal of Clinical Investigation|May 16, 1998
The full induction of human apoprotein A-I gene expression by the experimental nephrotic syndrome in transgenic mice depends on cis-acting elements in the proximal 256 base-pair promoter region and the trans-acting factor early growth response factor 1M Zaiou, N Azrolan, T Hayek, et al.
Pageof 7